Niveles de IgG anti-SARSCoV- 2 en población infantil de Nayarit, México, como biomarcador de inmunidad comunitaria. Estudio de caso a 17 meses de la pandemia por Covid-19
No disponible
Main Authors: | Gladys Alejandra Toledo-Ibarra, Carlos Eduardo Covantes-Rosales, Daniel Alberto Girón-Pérez, Adela Yolanda Bueno-Durán, Migdalia Sarahy Navidad-Murrieta, Manuel Iván Girón-Pérez |
---|---|
Format: | Article |
Language: | English |
Published: |
Instituto Nacional de Salud Pública
2021-11-01
|
Series: | Salud Pública de México |
Online Access: | https://www.saludpublica.mx/index.php/spm/article/view/13128 |
Similar Items
-
Inmunohistochemical detection of pandemic SARSCoV- 2 antigens in lung tissue
by: Jorge Alonso Rivera, et al.
Published: (2022-10-01) -
Vaccination against SARSCoV-19 among psychiatric patients at the central Greek hospital
by: M. E. Anagnostaki, et al.
Published: (2023-03-01) -
Is high Dose Intravenous Vitamin C Safe to Use in SARSCoV- 2 Treatment?
by: Abdurrahim Koçyiğit
Published: (2020-12-01) -
The Effectiveness of Hydroxychloroquine Versus Hydroxychloroquine Plus Lopinavir/Ritonavir Therapy in SARSCoV- 2 Pneumonia
by: Ayşe BATIREL, et al.
Published: (2021-12-01) -
Central retinal artery occlusion after vaccination with whole virion inactivated SARSCoV- 2 vaccine Covaxin
by: Meenakshi Thakar, et al.
Published: (2022-01-01)